Jennifer Shufro
@Alkeon Capital Management Llc
Latest period2024 - Q3ReportedManaged Assets$58.349BTotal holdings86
Assets growth rate-4.33%Assets growth rate (2-Q avg)0.18%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Alkeon Capital Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 86 positions.
Assets under management
The assets under management (AUM) of Alkeon Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 58.349B in assets, with a quarterly growth rate of -4.33% and a 2-quarter average growth rate of 0.18%. The portfolio is managed by Jennifer Shufro, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
SHWSherwin Williams Co
| 0.21% | $117.161M 306,970 shares@ $381.68 avg price | Decreased -0.09% |
KROSKeros Therapeutics Inc
| 0.19% | $110.194M 1.898M shares@ $58.07 avg price | Increased 18.69% |
SQBlock Inc
| 0.19% | $105.139M 1.566M shares@ $67.13 avg price | |
AMTAmerican Tower Corp New
| 0.18% | $99.705M 428,730 shares@ $232.57 avg price | Decreased -0.09% |
AKROAkero Therapeutics Inc
| 0.17% | $95.394M 3.325M shares@ $28.7 avg price | Decreased -0.06% |
SPGIS&p Global Inc
| 0.16% | $87.592M 169,548 shares@ $516.63 avg price | Decreased -0.08% |
SRPTSarepta Therapeutics Inc
| 0.14% | $79.161M 633,845 shares@ $124.9 avg price | Increased 13.43% |
BPMCBlueprint Medicines Corp
| 0.12% | $66.501M 718,928 shares@ $92.51 avg price | Decreased -19.57% |
YUMYum Brands Inc
| 0.12% | $65.098M 465,951 shares@ $139.72 avg price | Decreased -0.08% |
RYTMRhythm Pharmaceuticals Inc
| 0.11% | $61.176M 1.168M shares@ $52.39 avg price | Increased 16.77% |